Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × OTHER × Risk Reduction Behavior × Clear all

Status

Completed 13 Unknown 3 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 648 Neoplasms 410 Prostatic Neoplasms 355 Carcinoma, Non-Small-Cell Lung 349 Lung Neoplasms 279 Leukemia, Myeloid, Acute 275 Multiple Myeloma 243 Neoplasm Metastasis 217 Pancreatic Neoplasms 216 Leukemia 216 Colorectal Neoplasms 211 Lymphoma 193 Melanoma 191 Precursor Cell Lymphoblastic Leukemia-Lymphoma 188 Brain Neoplasms 177 Recurrence 160 Lymphoma, Non-Hodgkin 158 Head and Neck Neoplasms 156 Myelodysplastic Syndromes 154 Leukemia, Lymphocytic, Chronic, B-Cell 153 Ovarian Neoplasms 144 Glioblastoma 138 Carcinoma, Hepatocellular 135 Carcinoma, Renal Cell 120 Rectal Neoplasms 114 Lymphoma, Large B-Cell, Diffuse 113 Lymphoma, Follicular 113 Colonic Neoplasms 109 Hodgkin Disease 106 Glioma 100

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04998734 2023-05-11

ASI-SR

Uppsala University

Opioid-Related Disorders, Pain, Risk Reduction Behavior, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡